Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: ng/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
acs probability
—probability
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low Risk0–0.02
  • Low Risk0.02–0.05
  • Moderate Risk0.05–0.95
  • High Risk0.95–1
Direct Clinical Answer

The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include hs ctnt ng l. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Rules out acute coronary syndrome using high-sensitivity cardiac troponin T and clinical factors. Provides risk stratification for patients presenting with chest pain to the emergency department.

Clinical Indication

The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid is indicated for bedside clinical practice to support Rules out acute coronary syndrome using high-sensitivity cardiac troponin T and clinical factors. Provides risk stratification for patients presenting with chest pain to the emergency department.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring. Clinical exclusion: Not applicable to patients with STEMI or obvious ACS on presentation.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Uses only high-sensitivity cardiac troponin T (hs-cTnT) as biomarker, not serial measurements.

Formula & Variables:

Probabilistic model using logistic regression incorporating high-sensitivity cardiac troponin T concentration and clinical risk factors

Input Parameters

NameTypeRequiredDescription
hs_ctnt_ng_lfloatYesHigh-sensitivity cardiac troponin T concentration on arrival(ng/L)
ekg_ischemiastringYesPresence of ischemic changes on EKG
crescendo_anginastringYesWorsening or crescendo angina pattern
pain_right_armstringYesPain radiating to right arm or shoulder
vomitingstringYesPain associated with vomiting
sweatingstringYesSweating observed
hypotensionstringYesHypotension (systolic BP <100 mmHg)

Score Interpretation & Guidance

RangeStageDescription
0–0.02Very Low RiskACS ruled out
0.02–0.05Low RiskLow risk
0.05–0.95Moderate RiskIntermediate risk
0.95–1High RiskACS ruled in

Evidence-Based References (EBM)

  • Body R, Carlton E, Sperrin M, et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J. 2017;34(6):349-356.
  • Greenslade JH, Carlton EW, Van Hise C, et al. Diagnostic accuracy of the Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid with a point-of-care cardiac troponin assay. Acad Emerg Med. 2020;27(6):459-466.

Related calculators